Publication:
Pathological accuracy in prostate cancer: single-center outcomes of 3 different magnetic resonance imaging-targeted biopsy techniques and random systematic biopsy

dc.contributor.coauthorKılıç, Mert
dc.contributor.coauthorVural, Metin
dc.contributor.coauthorÇolakoğlu, Bülent
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAcar, Ömer
dc.contributor.kuauthorBalbay, Mevlana Derya
dc.contributor.kuauthorBaydar, Dilek Ertoy
dc.contributor.kuauthorCanda, Abdullah Erdem
dc.contributor.kuauthorÇil, Barbaros Erhan
dc.contributor.kuauthorEsen, Tarık
dc.contributor.kuauthorKordan, Yakup
dc.contributor.kuauthorKöseoğlu, Ersin
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T12:14:14Z
dc.date.issued2022
dc.description.abstractObjective: the aim of this study is to compare systematic, cognitive fusion, in-bore, and software fusion prostate biopsies regarding rates of and risk factors for pathological upgrading. Material and methods: charts of 291 patients with systematic biopsy (n = 105), magnetic resonance imaging-targeted cognitive fusion (n = 58), in-bore (n = 68), and software fusion biopsy (n = 60), and who subsequently underwent radical prostatectomy were retrospectively evaluated. The degree of similarity between the grade groups reported in the biopsy and radical prostatectomy pathology results was recorded. Analyses of the associated factors for concordance and discordance were performed with univariate and multivariate methods. Results: the concordance rates were as follows: systematic biopsy = 42.8%, cognitive fusion-targeted biopsy = 50%, in-bore fusion-targeted biopsy = 61.8, and software fusion biopsy = 58.4%. The upgrade rate of systematic biopsy (46.6%) was higher than cognitive fusion-targeted biopsy (27.6%), in-bore fusion-targeted biopsy (26.4%), and software fusion-targeted biopsy (18.3%). The number of positive cores was significantly associated with grade group concordance for the systematic biopsy group (P =.040). Within the cognitive fusion-targeted biopsy cohort, number of positive cores was the only parameter that exhibited a significant association with grade group concordance in multivariate analysis (P =.044). Considering the in-bore fusion-targeted biopsy group, maximum tumor length was statistically significant (P =.021). In the software fusion-targeted biopsy group, low prostate volume was found to be the only significant predictor for grade group accordance (P =.021). Conclusion: magnetic resonance imaging-targeted biopsy techniques showed higher concordance and lower upgrade rates compared to systematic biopsy. For systematic biopsy and cognitive fusion-targeted biopsy, the number of positive cores was associated with grade group concordance, while maximum tumor length in in-bore fusion-targeted biopsy and low prostate volume for in-bore fusion-targeted biopsy were associated with grade group concordance. Among the MRI-targeted biopsy methods, in-bore fusion-targeted biopsy and software fusion-targeted biopsy were more accurate than cognitive fusion-targeted biopsy in terms of grade group.
dc.description.fulltextYES
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.indexedbyTR Dizin
dc.description.issue5
dc.description.openaccessYES
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume48
dc.identifier.doi10.5152/tud.2022.22165
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03985
dc.identifier.issn2149-3235
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85139190239
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1280
dc.keywordsProstate cancer
dc.keywordsGleason score
dc.keywordsProstatectomy
dc.keywordsBiopsy
dc.keywordsMultiparametric MRI
dc.language.isoeng
dc.publisherAves
dc.relation.grantnoNA
dc.relation.ispartofTurkish Journal of Urology
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10861
dc.subjectBiopsy
dc.subjectGleason score
dc.subjectProstate-specific antigen
dc.titlePathological accuracy in prostate cancer: single-center outcomes of 3 different magnetic resonance imaging-targeted biopsy techniques and random systematic biopsy
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorAcar, Ömer
local.contributor.kuauthorÇil, Barbaros Erhan
local.contributor.kuauthorKöseoğlu, Ersin
local.contributor.kuauthorBaydar, Dilek Ertoy
local.contributor.kuauthorCanda, Abdullah Erdem
local.contributor.kuauthorKordan, Yakup
local.contributor.kuauthorBalbay, Mevlana Derya
local.contributor.kuauthorEsen, Tarık
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10861.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format